Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2002
06/13/2002WO2002003072A3 A method for extracting quantitative information relating to interactions between cellular components
06/13/2002WO2002002054A3 Methods and compositions for the diagnosis of schizophrenia
06/13/2002WO2002000858A3 Methods and compositions for simultaneous saccharification and fermentation
06/13/2002WO2002000729A3 Generation of libraries of antibodies in yeast and uses thereof
06/13/2002WO2002000704A3 Regulation of human phospholipase c-like enzyme
06/13/2002WO2002000701A3 Regulation of human gonadotropin releasing hormone receptor-like g protein-coupled receptor
06/13/2002WO2002000252A3 Non-human animal models of tolerance to hepatitis c virus immunogenes
06/13/2002WO2001098350A3 Compositions comprising net-4 modulations and their use for treating neoplastic disease
06/13/2002WO2001096377A3 Vaccine for congenital tremors in pigs
06/13/2002WO2001094564A3 Cis-zeatin o-glcocyltransferase from zea mays
06/13/2002WO2001094547A3 Molecular delivery vehicle for delivery of selected compounds to targets
06/13/2002WO2001094415A3 Nuclear hormone receptor
06/13/2002WO2001092294A3 Therapeutic anti-melanoma compounds
06/13/2002WO2001090364A3 Nucleic acid encoding a plant very long chain fatty acid biosynthetic enzyme
06/13/2002WO2001090188A3 Receptor-based interaction trap
06/13/2002WO2001090179A3 Novel human thrombospondin-like proteins and polynucleotides encoding the same
06/13/2002WO2001090159A3 Compositions and methods for delivery of a molecule into a cell
06/13/2002WO2001087981A3 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
06/13/2002WO2001087914A3 Plant gene targeting using oligonucleotides
06/13/2002WO2001083785A3 Regulated antigen delivery system (rads) involving bacteria
06/13/2002WO2001083550A3 Gpr22 modulators as appetite-control agents
06/13/2002WO2001083523A3 Stmst protein and nucleic acid molecules and uses therefor
06/13/2002WO2001081607A3 Adenovirus vectors with knobless fibers, and their uses
06/13/2002WO2001079486A3 Method and apparatus for plasmid recovery involving ultrafiltration
06/13/2002WO2001079289A3 Human interferon, zinf2
06/13/2002WO2001077372A3 Identification of biological (micro) organisms by detection of their homologous nucleotide sequences on arrays
06/13/2002WO2001077168A3 Compositions and methods for the therapy and diagnosis of lung cancer
06/13/2002WO2001072843A3 Regulation of human c-myb-related genes
06/13/2002WO2001071018A3 Secreting products from skin by adeno-associated virus (aav) gene transfer
06/13/2002WO2001068828A3 Compositions and methods for regulated protein expression in gut
06/13/2002WO2001064889A3 Tnf-alpha variants for the treatment of tnf-alpha related disorders
06/13/2002WO2001059108A3 Inhibitors of apoptosis
06/13/2002WO2001059103A3 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression
06/13/2002WO2001057242A3 Methods of protein destabilization and uses thereof
06/13/2002WO2001053526A3 Homogenous assay of duplex or triplex hybridization by means of multiple measurements under varied conditions
06/13/2002WO2001051663A3 Integrated systems and methods for diversity generation and screening
06/13/2002WO2001049854A3 Increased lysine production by gene amplification using coryneform bacteria
06/13/2002WO2001044300A3 Brain specific binding members
06/13/2002WO2001042461A3 Apoptin-associating protein
06/13/2002WO2001040798A3 Methods of using randomized libraries of zinc finger proteins for the identification of gene function
06/13/2002WO2001040280A3 Composition and method for treating a microbial infection
06/13/2002WO2001029256A3 Cephalic pain susceptibility marker
06/13/2002WO2001029239A3 Modified resistance genes
06/13/2002WO2000079009A9 Improved primers and methods for the detection and discrimination of nucleic acids
06/13/2002WO2000079008A9 High throughput assay system
06/13/2002WO2000078994A9 Compositions and methods for the quantification of sterol biosynthetic flux
06/13/2002WO2000078455A9 Devices and methods for the performance of miniaturized in vitro amplification assays
06/13/2002WO2000077262A9 Synthetic ligation reassembly in directed evolution
06/13/2002WO2000066741A3 Conserved neisserial antigens
06/13/2002WO2000064400A9 Methods for treating congestive heart failure
06/13/2002WO2000061736A9 Recombinant and mutant marek's disease virus
06/13/2002WO2000037610A3 Expression of immunogenic hepatitis b surface antigens in transgenic plants
06/13/2002US20020073448 Matrix attachment regions
06/13/2002US20020073447 Acquired resistance genes and uses thereof
06/13/2002US20020073446 Genetically modified plants having modulated brassinosteroid signaling
06/13/2002US20020073445 Methods for stable transformation of plants
06/13/2002US20020073444 Translational regulatory elements
06/13/2002US20020073443 Herbicide tolerance achieved through plastid transformation
06/13/2002US20020073442 Nucleotide sequences for use in the generation of disease resistant plants
06/13/2002US20020073441 Polypeptide for use in treatment of Alzheimer's, Parkinson's, Huntington's, spino-cerebellar ataxias, muscular disorders, multiple sclerosis, blood disorders, reperfusion injury, arthritis and graft vs host disorder
06/13/2002US20020073440 Screening for modulators of binding protein activity; obtain tissue, incubate with modulator, monitor activity of tissues
06/13/2002US20020073439 Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including Parkinson's disease
06/13/2002US20020073438 Methods of purifying human acid alpha-glucosidase
06/13/2002US20020072596 Nucleotide sequences coding transrerrins; for use in the treatment of nervous system., blood abbd anemia, heme biosynthesis disorders
06/13/2002US20020072595 Nucleic acid for use in kits for detection of preferential bacterial infection
06/13/2002US20020072594 Pools of nucleotide sequences; for use as diagnostic and therapeutic tools in the treatment of autoimmune diseases
06/13/2002US20020072592 Nucleotide sequences which code anticarcinogenic agent for use in the treatment mammary gland cancer
06/13/2002US20020072589 Insulin-like growth factor binding protein variants
06/13/2002US20020072504 Method and reagents for genetic immunization
06/13/2002US20020072503 Compositions and methods for the therapy and diagnosis of ovarian cancer
06/13/2002US20020072497 Novel DNA and recombinant production of novel polypeptides
06/13/2002US20020072496 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/13/2002US20020072494 Angiogenesis inhibitor, K1-5 (protease-activated kringles 1-5) genetically engineered so it can be secreted from cells in which it is expressed; contains a secretory signal peptide and a pre-activation peptide derived from plasminogen
06/13/2002US20020072491 Homology to members of the myosin light chain kinase subfamily
06/13/2002US20020072488 Amino acid sequences of human transporter peptides and proteins that are related to the sugar transporter subfamily; identifying modulators of the transporter peptides
06/13/2002US20020072121 Composition for use in stable transfer on nucleotide sequences into cells
06/13/2002US20020072120 Helper viruses for the preparation of recombinant viral vectors
06/13/2002US20020072117 Human feeder cells that support proliferation of undifferentiated pluripotent stem cells
06/13/2002US20020072110 Isolating nucleotide sequences from sample; obtain sample inoculate with bacteria, precipate nucleotide sequences with ethanol and detergent, incubate nucleotide sequence sample with membrane, release the nucleic acid from the membrane
06/13/2002US20020072107 Human osteoclast derived cathepsin
06/13/2002US20020072106 Peptides selected by homology and/or structural relatedness to known protease proteins of the choriolytic hatching protease subfamily and expression pattern observed
06/13/2002US20020072101 Novel human nucleic acid molecules and polypeptides encoding cation channels
06/13/2002US20020072098 Generation of threonine; obtain cells, transform with vector coding threonine, ferment, recover threonine
06/13/2002US20020072097 Molecular breeding of transposable elements
06/13/2002US20020072094 Generating viral particles; obtain nucleotide sequences, package into vector, insert vector into cells, induce viral particle assembly, recoevr viral particles
06/13/2002US20020072093 Novel leader peptides for enhancing secretion of recombinant protein from a host cell
06/13/2002US20020072092 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/13/2002US20020072091 Death domain containing receptor 5
06/13/2002US20020072090 Hr-1 receptor
06/13/2002US20020072088 Monitoring protein associations and activity; obtain cells, measuring expression of reporter genes, adjustment in expression indicates modulatory activity
06/13/2002US20020072087 Nucleotide seqences for use in classifying genomes
06/13/2002US20020072080 Immunological materials and methods for detecting dihydropyrimidine dehydrogenase
06/13/2002US20020072075 Screening for enzyme inhibitors; obtain cells, incubate with modulator, monitor enzymatic activity of cells
06/13/2002US20020072070 Hybridization reaction apparatus and hybridization method
06/13/2002US20020072068 Spotting pin and device for fabricating biochips
06/13/2002US20020072067 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/13/2002US20020072066 Human osteoporosis gene
06/13/2002US20020072062 Generating clne containing chloramphenicol gene cluster; obtain microgranism, extract genome, form library, transform cells, screen clones for chloramphenicol expression
06/13/2002US20020072061 Methods and compositions for use in synthesizing nucleic acids
06/13/2002US20020072060 Screening sample for presence of preferential nucleotide sequences; obtain sample, incubate extraction mixture, expose to microarray, incubate with probe, monitor hybridization pattern
1 ... 2787 2788 2789 2790 2791 2792 2793 2794 2795 2796 2797 2798 2799 2800 2801 2802 2803 2804 2805 2806 2807 ... 4023